HealthEquity, Inc. (NASDAQ:HQY) Q1 2024 Earnings Conference Call June 5, 2023 4:30 PM ET

Company Participants

Richard Putnam - Investor Relations

Jon Kessler - President and Chief Executive Officer

Tyson Murdock - Executive Vice President and Chief Financial Officer

Steve Neeleman - Vice Chair and Founder of the company

Conference Call Participants

Glen Santangelo - Jefferies

Stan Berenshteyn - Wells Fargo

Anne Samuel - JPMorgan

George Hill - Deutsche Bank

Greg Peters - Raymond James

Sandy Draper - Guggenheim

David Larsen - BTIG

Scott Schoenhaus - KeyBanc

Stephanie Davis - SVB Bank

Mark Marcon - Baird

Allen Lutz - Bank of America

Operator

Good day and welcome.

I would now like to turn the conference over to Richard Putnam to HealthEquity’s Earnings Call. Please go ahead.

Richard Putnam

Thank you, Sara. Hello, everyone. Welcome to HealthEquity's first quarter of fiscal year 2024 earnings conference call. My name is Richard Putnam, Investor Relations for HealthEquity and joining me today on the call is Jon Kessler, President and CEO, Dr. Steve Neeleman, our Vice Chair and Founder of the company, and Tyson Murdock, the company's Executive Vice President and CFO.

Before I turn the call over to Jon, I have two important reminders. First, a press release announcing our financial results for the first quarter of fiscal 2024 was issued after the market close this afternoon. The financial results included contributions from our wholly owned subsidiaries and accounts they administer. The press release also includes definitions of certain non-GAAP financial measures that we will reference today. A copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures and a recording of this webcast can be found on our Investor Relations website, which is ir.healthequity.com.

Second, our comments and responses to your questions today reflect management's view as of today, June 5, 2023, and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates or other information that might be considered forward-looking. There are many important factors relating to our business, which could affect the forward-looking statements made today. These forward-looking statements are subject to risk and uncertainties that may cause our actual results to differ materially from statements made here today. We caution against placing undue reliance on these forward-looking statements, and we also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock as detailed inour annual report on Form 10-K and subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events.